Fate Therapeutics to present FT819 Encore clinical data at CCR West 2026
Fate Therapeutics said it will present encore clinical data for its FT819 off-the-shelf CAR T-cell product candidate at the CCR West 2026 meeting.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.